CHA Biotech to co-develop NK cell therapy with US biotech CanCure : vimarsana.com

CHA Biotech has entered into a collaboration with U.S. immunotherapy biotech company CanCure to develop a natural killer (NK) cell therapy, the company said Monday.

Related Keywords

Gyeonggi , Kyonggi Do , South Korea , Seongnam , Centenaire Biosciences , Lee Jung Hyun , Baek Byung Yeul , Bio Group , Bio Group Seen , Gyeonggi Province , Biotech , Nk , Company , Combination , Cell , Antibodies , Therapy , Cha , Antibody , Cancer , Orea , Outh Korea , He Korea Times , Orea Times , Oreatimes , Orean News In English ,